2006: A Beginning with G9 Bananas
Genewin Biotech was founded in 2006, hitting the ground running with the production of the G9 banana variety. This was just the first step in a journey that would make Genewin a household name in tissue culture in India.
2008: Pioneering Local Banana Varieties
By 2008, Genewin had successfully pioneered the large-scale tissue culture production of two local banana varieties: Monthan and Red banana. This was a massive leap in terms of both technological innovation and market coverage.
2011: Tackling the Yelakki Challenge
In 2011, overcoming numerous challenges, Genewin standardized the tissue culture protocol for Yelakki, a particularly tough banana variety. It then began large-scale production after a two-year development period.
2012: Diversification and Bioenergy Ventures
In collaboration with a major Indian energy company, we established the protocol for bambusa balcooa, intended for a bioenergy project. 2012 also saw an expansion of our banana portfolio to include Karpuravalli, Nendran, and Rasthali.
2014: Breaking New Ground with Vanilla
In a groundbreaking partnership with a Madagascar-based firm, Genewin became the first in India to produce tissue cultured vanilla plants. This engagement was under a two-year contractual agreement.
2015: Firsts in Bamboo Varieties
We introduced Tissue Culture Dendrocalamus asper, Bambusa nutans, and Bambusa Tulda to the Indian market, being the first in India to standardize their tissue culture protocols and offer these varieties.
2017: Breaking New Record in Ginger
As per encouragement from IISR (Indian Institute of Spices Research) under ICAR (Indian Council of Agricultural Research), Genewin became the licensee for IISR Varada ginger production in India, standardised protocol for Ginger . This year also marked the commercial production of TC D.Brandisii and D. Stocksii bamboo varieties.
2018: Black Turmeric Milestone
Another feather in our cap was the standardization of the protocol for black turmeric tissue culture plants, making us the first in India to achieve this feat.
2019: Adding to the Portfolio
2019 saw further diversification with the introduction of T. Oliveri, D. Latiflorus, and B. Vulgaris green, following successful protocol standardization.
2020: The Rose Araca Savi Initiative
Genewin undertook the standardization of Rose Araca Savi, laying the groundwork for its large-scale production in the near future.
2022: Expanding Horizons
The latest addition to our portfolio includes teak, mahogany, and red sandal, underlining our commitment to diversification and innovation.
